INTERNATIONAL PATENT: STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD., 舒泰神（北京）生物制药股份有限公司 FILES APPLICATION FOR "NGF-FC FUSION PROTEIN FORMULATION AND USE THEREOF"

GENEVA, April 19 -- STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. (NO.36, Jinghai Er Road, Beijing Economic-Technological Development AreaDaxing District, Beijing 100176), 舒泰神（北京）生物制药股份有限公司 (中国北京市大兴区北京经济技术开发区经海二路36号) filed a patent application (PCT/CN2024/124343) for "NGF-FC FUSION PROTEIN FORMULATION AND USE THEREOF" on Oct 12, 2024. With publication no. WO/2025/077862, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent app...